Answers are grounded in this paper and cite their sources.
We applied the deep eutectic solvent (DES) extraction for analyzing capecitabine (Cape), 5’-deoxy-5-fluorocytidine (DFCR), 5’-deoxy-5-fluorouridine (DFUR), and 5-fluorouracil (5-FU) in human plasma with LC–UV method. In this method, the DES, which was prepared by mixing trioctylmethylammonium chloride and pentafluorophenol in a 1:2 molar ratio, was used as extraction solvent for target analytes in the sample solution. The target analytes extracted by DES was then injected into a reversed-phase LC–UV system and were detected with ultraviolet at 270 nm for 5-FU, DFCR, and DFUR, and at 240 nm for Cape. Under the optimized conditions, this extraction resulted in enrichment factors for Cape, DFCR, DFUR, and 5-FU, ranging from 1.4 to 5.6. The determination coefficients of the calibration curves were r2 > 0.9952 in the range of 0.05–10 µg/mL. The limits of detection and quantification ranged from 1.9 to 4.4 and from 6.4 to 14.7 ng/mL, respectively. The relative standard deviations of the peak areas obtained during intra-day determinations were within 9.8 %. The proposed method was further validated by the analysis of spiked human plasma samples.
No takes yet. Share an insight, caveat, or question.
TAKADA et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: